Raising Health cover image

Raising Health

The Science and Supply of GLP-1s with Carolyn Jasik

May 28, 2024
Carolyn Jasik, Chief Medical Officer of Omada Health, discusses the science of GLP-1 medications, including satiety effects, perspectives of obesity-focused physicians, and lifestyle implications for patients. They explore the transformative potential, comprehensive care strategies, and impact on behavior change. Practical tips for healthy eating on the go are also shared.
29:42

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • GLP-1 medications offer promising weight loss results, potentially transforming societal norms around food consumption.
  • Companion programs for GLP-1 medications can enhance patient support and manage side effects, driving future variations for chronic conditions.

Deep dives

Overview of GLP1 Medications

GLP1 medications have evolved over time, transitioning from daily to monthly dosing with improved side effect profiles. The medications are now categorized as anti-obesity drugs and show significant promise for weight loss, unlike previous disappointing outcomes in the field of obesity treatment.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode